Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalyn B Irby

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Biology & Therapy|August 21, 2010
Epidermal growth factor receptor revisited: prognostic marker or target for therapy?Rosalyn B Irby
Cancer Research|May 1, 2002
Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cellsRosalyn B Irby, Timothy J Yeatman
Cancer Biology & Therapy|November 11, 2016
TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cellsJeffrey Q Nguyen, Rosalyn B Irby
Apoptosis : an International Journal on Programmed Cell Death|September 13, 2011
The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FUChristina Leah B Kline, Rosalyn B Irby
Expert Opinion on Therapeutic Targets|October 16, 2012
Par-4 as a potential target for cancer therapyRosalyn B Irby, Christina L B Kline
Molecular and Cellular Endocrinology|August 2, 2003
Peroxisome proliferator-activated receptor alpha induces rat sterol carrier protein x promoter activity through two peroxisome proliferator-response elementsDayami Lopez, Rosalyn B Irby, Mark P McLean
Diseases of the Colon and Rectum|February 23, 2010
Tumor necrosis factor alpha induces p53 up-regulated modulator of apoptosis expression in colorectal cancer cell linesDanielle M Pastor, Rosalyn B Irby, Lisa S Poritz
Clinical & Experimental Metastasis|October 8, 2008
Src activity alters alpha3 integrin expression in colon tumor cellsChristina Leah B Kline, Thomas L Olson, Rosalyn B Irby
Cancer Biology & Therapy|September 5, 2009
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FUChristina L Kline, Sriram S Shanmugavelandy, Mark Kester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2011
The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse modelArun K Sharma, Christina L Kline, Arthur Berg, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|August 21, 2010
Epidermal growth factor receptor revisited: prognostic marker or target for therapy?Rosalyn B Irby
Cancer Research|May 1, 2002
Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cellsRosalyn B Irby, Timothy J Yeatman
Cancer Biology & Therapy|November 11, 2016
TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cellsJeffrey Q Nguyen, Rosalyn B Irby
Apoptosis : an International Journal on Programmed Cell Death|September 13, 2011
The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FUChristina Leah B Kline, Rosalyn B Irby
Expert Opinion on Therapeutic Targets|October 16, 2012
Par-4 as a potential target for cancer therapyRosalyn B Irby, Christina L B Kline
Molecular and Cellular Endocrinology|August 2, 2003
Peroxisome proliferator-activated receptor alpha induces rat sterol carrier protein x promoter activity through two peroxisome proliferator-response elementsDayami Lopez, Rosalyn B Irby, Mark P McLean
Diseases of the Colon and Rectum|February 23, 2010
Tumor necrosis factor alpha induces p53 up-regulated modulator of apoptosis expression in colorectal cancer cell linesDanielle M Pastor, Rosalyn B Irby, Lisa S Poritz
Clinical & Experimental Metastasis|October 8, 2008
Src activity alters alpha3 integrin expression in colon tumor cellsChristina Leah B Kline, Thomas L Olson, Rosalyn B Irby
Cancer Biology & Therapy|September 5, 2009
Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FUChristina L Kline, Sriram S Shanmugavelandy, Mark Kester, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2011
The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse modelArun K Sharma, Christina L Kline, Arthur Berg, et al.
Pageof 2